Kathleen N. Moore, MD
Associate Professor
The University of Oklahoma
800 NE 10th St
Suite 5050
Oklahoma City,
OK
USA
73104
Biographical Sketch: Kathleen Moore is assistant professor of gyn oncology at the university of oklahoma where she serves as associate fellowship director and associate director of phase I clinical trials. She holds the Mai Eager Anderson Chair in Cancer Clinical Trials and serves and GOG Co-PI for the University of Oklahoma.
Papers:
51
A Phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: a Gynecologic Oncology Group study
53
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study
108
Post intensive care unit syndrome in women with gynecologic cancer
116
Provision of primary palliative care by gynecologic oncologists
237
Integration of adjuvant chemotherapy in first-line management of uterine carcinosarcoma
312
Prospective correlation of multinational association for supportive care in cancer risk index score with outcomes in neutropenic fever
434
Multi-institutional validation of decreased survival with venous thromboembolism in ovarian clear cell carcinoma
451
Comorbid case-mix and predictors of inpatient admissions or death among ovarian cancer patients presenting to emergency departments in the United States
486
Identifying gynecologic oncology patients with high symptom burden
Beyond histology - an overview of biomarkers for the allied provider